Arshak R Alexanian
Overview
Explore the profile of Arshak R Alexanian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhang Z, Alexanian A
J Cell Mol Med
. 2012 Jun;
16(11):2708-14.
PMID: 22681532
A number of recent studies have examined the ability of stem cells derived from different sources to differentiate into dopamine-producing cells and ameliorate behavioural deficits in Parkinsonian models. Recently, using...
12.
Zhang Z, Alexanian A
J Tissue Eng Regen Med
. 2012 Jun;
8(5):407-13.
PMID: 22674835
Mesenchymal stem cells (MSCs) in their immature state express a variety of genes of the three germ layers at relatively low or moderate levels that might explain their phenomenal plasticity....
13.
Alexanian A, Fehlings M, Zhang Z, Maiman D
Neurorehabil Neural Repair
. 2011 Aug;
25(9):873-80.
PMID: 21844281
Background: Stem cell-based therapy for repair and replacement of lost neural cells is a promising treatment for central nervous system (CNS) diseases. Bone marrow (BM)-derived mesenchymal stem cells (MSCs) can...
14.
Zhang Z, Maiman D, Kurpad S, Crowe M, Alexanian A
Cell Reprogram
. 2011 Jul;
13(5):385-90.
PMID: 21718099
Recent studies suggest that cellular therapies that utilize mesenchymal stem cells (MSCs), especially ones that have been neurally induced (NI), may provide a functional benefit in a wide range of...
15.
Alexanian A, Kwok W, Pravdic D, Maiman D, Fehlings M
Restor Neurol Neurosci
. 2011 Jan;
28(6):761-7.
PMID: 21209491
Purpose: We recently developed a new method for efficient generation of neural-like cells from mice bone marrow (BM)-derived mesenchymal stem cells (MSC) by exposing MSCs to epigenetic modifiers and a...
16.
Alexanian A
Regen Med
. 2010 Nov;
5(6):891-900.
PMID: 21082889
Background: Stem cell-based therapies to repair and replace lost neural cells are a highly promising treatment for CNS diseases. Bone marrow (BM)-derived mesenchymal stem cells (MSCs) have great potential as...
17.
Alexanian A, Svendsen C, Crowe M, Kurpad S
Cytotherapy
. 2010 Aug;
13(1):61-8.
PMID: 20735167
Background Aims: Traumatic injuries of the central nervous system cause damage and degeneration of specific cell populations with subsequent functional loss. Cell transplantation is a strategy to treat such injuries...
18.
Alexanian A, Maiman D, Kurpad S, Gennarelli T
Stem Cells Dev
. 2008 May;
17(6):1123-30.
PMID: 18484898
Mesenchymal stem cell (MSC)-mediated tissue regeneration is a promising strategy to treat several neurodegenerative diseases and traumatic injuries of the central nervous system. Bone marrow MSCs have great potential as...
19.
Alexanian A
J Cell Biochem
. 2006 Aug;
100(2):362-71.
PMID: 16924670
Understanding mechanisms that govern cell fate decisions will lead to developing techniques for induction of adult stem cell differentiation to desired cell outcomes and, thus, production of an autologos source...
20.
Macias M, Syring M, Pizzi M, Crowe M, Alexanian A, Kurpad S
Exp Neurol
. 2006 Jul;
201(2):335-48.
PMID: 16839548
Transplantation of neural stem cells (NSCs) in the injured spinal cord has been shown to improve functional outcome; however, recent evidence has demonstrated forelimb allodynia following transplantation of embryonic NSCs....